Sarpagandha (Rauwolfia serpentina): Reserpine, History & Serious Safety Risks

TL;DR

Sarpagandha (Rauwolfia serpentina) root is the source of reserpine, a 1950s prescription blood-pressure drug. Reserpine depletes brain monoamines and can cause severe depression with suicidal ideation, parkinsonism, and dangerous interactions with MAOIs, antidepressants, digoxin and other medicines. Never use sarpagandha to self-treat hypertension or replace prescribed medication.

What it is

Sarpagandha is the root of Rauwolfia serpentina (L.) Benth. ex Kurz (family Apocynaceae), known as Indian snakeroot or serpentine wood (Strawbridge et al., J Psychopharmacol 2023). The root is the source of reserpine, a prescription antihypertensive isolated in 1952 that irreversibly inhibits the vesicular monoamine transporter (VMAT), depleting central and peripheral stores of dopamine, serotonin and norepinephrine (same review; Rijntjes & Meyer, Front Neurol 2019). Whole-root products also contain reserpine: reported root contents reach about 3%, and commercial herbal preparations may contain roughly 0.02–0.08 mg per unit (Rijntjes & Meyer 2019).

Traditional use

Sarpagandha has been used for centuries in Indian medicine, including as a tranquilizer for nervous disorders (Rijntjes & Meyer 2019; Strawbridge et al. 2023). In the 20th century, the root entered Western medicine: reserpine became commercially available in 1952 as the first drug to treat hypertension successfully, and the whole root found use in psychiatry: but this medical history is inseparable from serious adverse effects (Strawbridge et al. 2023). Traditional and historical use is not evidence of safety; the safety record is assessed below.

What modern research says

Hypertension (historical evidence, now second-line)

Reserpine was the first successful hypertension drug and became a first-line antihypertensive in the 1950s. Its use "fell dramatically" after case reports of depression and parkinsonism, and it is now considered a second-line option used occasionally when other drugs cannot be used (Strawbridge et al. 2023). Its efficacy against hypertension is historical and established: the reason it is rarely prescribed today is its adverse-effect profile, not lack of efficacy (same review).

Depression risk (systematic review of the evidence)

A 2023 systematic review identified 35 studies (including 9 randomized controlled trials) on reserpine and depression: 11 reported depressogenic effects, 13 reported no effect, and 11 reported possible antidepressant effects: with 30 of 35 studies at high risk of bias (Strawbridge et al. 2023). The evidence is scientifically inconsistent, but the safety signal is real: early case reports (1954) described sadness, fatigue and suicidal ideation in patients on larger doses, and current prescribing information carries explicit warnings (same review; reserpine package insert). An inconsistent research literature does not override the label's contraindications and warnings.

Real-world harm from Ayurvedic products (case report)

A 2019 case report documented a patient who developed parkinsonism and depression after about three years of taking Ayurvedic products (normalin and serpina) containing Rauwolfia serpentina root extract. WHO-UMC causality assessment for the parkinsonism was "certain," and symptoms resolved after withdrawal (Rijntjes & Meyer 2019). The authors warned that the old assumption that doses around 0.25 mg/day are safe rests on weak historical evidence, "and the present case suggests that a harmful dose might be much lower than this" (same report). "Natural" and "Ayurvedic" do not mean safe.

What the evidence does not support (yet)

Sarpagandha is not a safe or recommended treatment for hypertension, insomnia, anxiety or mental illness by any modern standard. Its historical psychiatric uses belong to an era before these risks were understood (Strawbridge et al. 2023).

Dosage

This article gives no dosage for sarpagandha. Reserpine is a prescription drug dosed by physicians. There is no safe self-use dose of the root, and even low estimated exposures have been associated with serious harm in a published case (Rijntjes & Meyer 2019). Do not use sarpagandha products to self-treat any condition.

Safety & contraindications

This is the critical section. The following comes from the FDA-approved reserpine package insert and must be treated as binding for any product containing reserpine (reserpine package insert):

Reported side effects include nasal congestion, gastrointestinal upset, bradycardia, dizziness, drowsiness, fluid retention, weight gain, sexual dysfunction, and parkinsonism (drugs.com side effects). Never use sarpagandha to self-treat hypertension, and never stop or replace prescribed blood-pressure medication with it. Any use requires clinician and pharmacist supervision.

FAQs

Can I use sarpagandha for high blood pressure?

No. It is not a safe or recommended treatment for hypertension. See a doctor; do not replace prescribed blood-pressure medication with sarpagandha or stop prescribed drugs (reserpine package insert).

What is reserpine?

Reserpine is an alkaloid isolated from Rauwolfia serpentina root in 1952. It irreversibly inhibits VMAT, depleting dopamine, serotonin and norepinephrine, and was the first successful prescription drug for hypertension (Strawbridge et al. 2023).

Can reserpine cause depression?

Yes: it can. A 2023 systematic review found the research literature inconsistent (11 of 35 studies depressogenic, 30 at high risk of bias), but prescribing information explicitly warns that depression may occur, persist for months after stopping, and may result in suicide (Strawbridge et al. 2023; package insert).

What drugs interact with reserpine/sarpagandha?

MAO inhibitors (avoid/extreme caution), tricyclic antidepressants, sympathomimetics, digitalis/digoxin and quinidine, and other blood-pressure drugs (package insert).

Is sarpagandha safe because it is Ayurvedic and natural?

No. A published case report linked Ayurvedic products containing Rauwolfia serpentina root extract to parkinsonism and depression that resolved only after the products were stopped (Rijntjes & Meyer 2019).

Why did doctors stop prescribing reserpine?

After case reports of depression (including suicidal ideation) and parkinsonism, its use fell dramatically. It is now a second-line drug used only occasionally when others cannot be used (Strawbridge et al. 2023).

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Sarpagandha contains reserpine, a drug with serious risks including depression, parkinsonism and dangerous interactions. Never use it to self-treat hypertension or any condition, and never stop or replace prescribed medication. Talk to a qualified healthcare practitioner — and a pharmacist — before considering any product containing Rauwolfia.